BioNTech authorizes $1 billion share repurchase program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/22/2026
- Wall St futures edge lower as caution builds ahead of Big Tech earnings
- Oil climbs over 3% to near six-week high as conflict threatens key oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
- Foreign buying surge may signal trouble ahead for the S&P 500
- Reddit shares drop as threat to cut off Google AI sparks standoff
- Emirates refusing to take delivery of first 10 Boeing 777X jets
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- Wall St ends higher on chip stocks recovery; earnings in focus
- Palo Alto Networks to acquire Embrace to expand observability tools
- Myriad Genetics launches four-in-one prenatal genetic screen
BioNTech Announces New ADS Repurchase Program
May 7, 2026 6:45 AM EDTMAINZ, Germany, May 7, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, BioNTech or the Company) today announced that it has authorized a new share repurchase program (the Program), under which the Company may repurchase American Depositary Shares (ADSs), each representing one ordinary share of the Company, for an aggregate amount of up to $1.0 billion. Repurchases under the Program may be made until and including May 6, 2027. BioNTechs disciplined... More
